Jun 14, 2021 7:01pm Ada Health’s smartphone app, which uses artificial intelligence to analyze a user’s self-reported symptoms and suggest a list of potential causes, has already attracted plenty of attention from Big Pharma, including a Bayer-led series B and a recently expanded collaboration with Novartis. (Ada Health) Typically, when pharmaceutical companies turn to medtech developers for support, they’re in the market to boost their drug discovery and development capabilities with the help of a shiny new artificial intelligence tool or to deploy a smartphone app to monitor the effects of an already available drug. But the software developer currently making big waves across Big Pharma is focused on intervening much earlier in the treatment process—at the very beginning, in fact, before treatment has even begun.